TY - JOUR
T1 - The European Prostate Cancer Centres of Excellence: A Novel Proposal from the European Association of Urology Prostate Cancer Centre Consensus Meeting
AU - Wirth, Manfred
AU - Fossati, Nicola
AU - Albers, Peter
AU - Bangma, Chris
AU - Brausi, Maurizio
AU - Comperat, Eva
AU - Faithfull, Sara
AU - Gillessen, Silke
AU - Jereczek-Fossa, Barbara Alicja
AU - Mastris, Ken
AU - Mottet, Nicolas
AU - Müller, Stefan C.
AU - Pieters, Bradley
AU - Ribal, Maria J.
AU - Sangar, Vijay
AU - Schoots, Ivo G.
AU - Smelov, Vitaly
AU - Travado, Luzia
AU - Valdagni, Riccardo
AU - Wesselmann, Simone
AU - Wiegel, Thomas
AU - van Poppel, Hendrik
N1 - Funding Information: Creation of the EPCCE was a multidisciplinary project that consisted of different steps. Initially, the European Association of Urology (EAU) representatives (M.W., H.V.P., and P.A.) organised a multiprofessional task force, where the representatives of the major international oncological societies and organisations were invited to participate and nominate their representatives. The invitation was accepted by the European School of Oncology (ESO), the European Organization for Research and Treatment of Cancer, the European Society for Radiotherapy and Oncology (ESTRO), Europa Uomo (EUomo), the German Cancer Society (Deutsche Krebsgesellschaft [DKG]), the International Agency for Research on Cancer, the Specialized Cancer Agency of the World Health Organization, the International Psycho-Oncology Society (IPOS), and the European Board of Urology (EBU). Furthermore, different sections of the EAU were involved in this project, including the EAU Guideline Office, the EAU Section of Oncological Urology (ESOU), the EAU Section of Uro-Pathology (ESUP), the EAU Section of Urological Research (ESUR), the European Urological Scholarship Programme Office (EUSP), and the EAU Nurses (EAUN). The multiprofessional task force was created in order to include representatives from all the different cancer specialities: urologists—N.F., C.B., N.M., M.B., M.R., and V.S.; radiation oncologists—R.V., T.W., B.A.J.F., and B.P.; medical oncologists—S.G. and S.W.; pathologists—E.C.; radiologists—I.G.S.; nurses—S.F.; psycho-oncologists—L.T.; and patient advocate organisations—K.M. The task force aimed at identifying the standards to define the EPCCE. Specifically, the required criteria were grouped into three main topics: (1) clinics, (2) research, and (3) education. A fourth step related to the assessment of the quality of the three previous topics was defined. Discussion took place in conference calls and by e-mail from March 2017 to November 2017, and the final consensus meeting named “EAU Prostate Cancer Centre Consensus Meeting” (EPCCCM) was held in Barcelona on November 16, 2017. The aim of the discussion was to evaluate the applicability of the criteria in routine clinical practice and in the different health contexts of all European countries. The task force experts reviewed, through an iterative process, comprehensive multidisciplinary guidelines and literature within the framework described, thereby leading to a consensus on the standards for excellence of PCa care. 3 Publisher Copyright: © 2019 European Association of Urology Copyright: Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2019/8/1
Y1 - 2019/8/1
N2 - Background: High-quality management of prostate cancer is needed in the fields of clinics, research, and education. Objective: The objective of this project was to develop the concept of “European Prostate Cancer Centres of Excellence” (EPCCE), with the specific aim of identifying European centres characterised by high-quality cancer care, research, and education. Design, setting, and participants: A task force of experts aimed at identifying the general criteria to define the EPCCE. Discussion took place in conference calls and by e-mail from March 2017 to November 2017, and the final consensus meeting named “European Association of Urology (EAU) Prostate Cancer Centre Consensus Meeting” was held in Barcelona on November 16, 2017. Outcome measurements and statistical analysis: The required criteria were grouped into three main steps: (1) clinics, (2) research, and (3) education. A quality control approach for the three steps was defined. Results and limitations: The definition of EPCCE consisted of the following steps: (1) clinical step—five items were identified and classified as core team, associated services, multidisciplinary approach, diagnostic pathway, and therapeutic pathway; (2) research step—internal monitoring of outcomes was required; clinical data had to be collected through a prespecified database, clinical outcomes had to be periodically assessed, and prospective trials had to be conducted; (3) educational step—it consists of structured fellowship programmes of 1 yr, including 6 mo of research and 6 mo of clinics; and (4) quality assurance and quality control procedures, related to the quality assessment of the previous three steps. A limitation of this project was that the definition of standards and items was mainly based on a consensus among experts rather than being an evidence-based process. Conclusions: The EAU Prostate Cancer Centre Consensus Meeting defined the criteria for the identification of the EPCCE in the fields of clinics, research, and education. The inclusion of a quality control approach represents the novelty that supports the excellence of these centres. Patient summary: A task force of experts defined the criteria for the identification of European Prostate Cancer Centres of Excellence, in order to certify the high-quality centres for prostate cancer management. The European Association of Urology Prostate Cancer Centre Consensus Meeting defined the criteria for the identification of European Prostate Cancer Centres of Excellence in the field of clinics, research, and education. The inclusion of a quality control approach represents the novelty that supports the excellence of these centres.
AB - Background: High-quality management of prostate cancer is needed in the fields of clinics, research, and education. Objective: The objective of this project was to develop the concept of “European Prostate Cancer Centres of Excellence” (EPCCE), with the specific aim of identifying European centres characterised by high-quality cancer care, research, and education. Design, setting, and participants: A task force of experts aimed at identifying the general criteria to define the EPCCE. Discussion took place in conference calls and by e-mail from March 2017 to November 2017, and the final consensus meeting named “European Association of Urology (EAU) Prostate Cancer Centre Consensus Meeting” was held in Barcelona on November 16, 2017. Outcome measurements and statistical analysis: The required criteria were grouped into three main steps: (1) clinics, (2) research, and (3) education. A quality control approach for the three steps was defined. Results and limitations: The definition of EPCCE consisted of the following steps: (1) clinical step—five items were identified and classified as core team, associated services, multidisciplinary approach, diagnostic pathway, and therapeutic pathway; (2) research step—internal monitoring of outcomes was required; clinical data had to be collected through a prespecified database, clinical outcomes had to be periodically assessed, and prospective trials had to be conducted; (3) educational step—it consists of structured fellowship programmes of 1 yr, including 6 mo of research and 6 mo of clinics; and (4) quality assurance and quality control procedures, related to the quality assessment of the previous three steps. A limitation of this project was that the definition of standards and items was mainly based on a consensus among experts rather than being an evidence-based process. Conclusions: The EAU Prostate Cancer Centre Consensus Meeting defined the criteria for the identification of the EPCCE in the fields of clinics, research, and education. The inclusion of a quality control approach represents the novelty that supports the excellence of these centres. Patient summary: A task force of experts defined the criteria for the identification of European Prostate Cancer Centres of Excellence, in order to certify the high-quality centres for prostate cancer management. The European Association of Urology Prostate Cancer Centre Consensus Meeting defined the criteria for the identification of European Prostate Cancer Centres of Excellence in the field of clinics, research, and education. The inclusion of a quality control approach represents the novelty that supports the excellence of these centres.
KW - Criteria
KW - European Prostate Cancer Centre of Excellence
KW - Multidisciplinary approach
KW - Prostate cancer
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85061774968&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/30799188
UR - http://www.scopus.com/inward/record.url?scp=85061774968&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.eururo.2019.01.033
DO - https://doi.org/10.1016/j.eururo.2019.01.033
M3 - Article
C2 - 30799188
SN - 0302-2838
VL - 76
SP - 179
EP - 186
JO - European Urology
JF - European Urology
IS - 2
ER -